Full Text Journal Articles from
Abstract 35731675

Advertisement

Find full text journal articles








Electronic health strategies to improve medication adherence in patients with cardiometabolic disease: current status and future directions.

PMID: 35731675 (view PubMed database entry)
DOI: 10.1097/hco.0000000000000971 (read at publisher's website )

Erin Peacock, Leslie S Craig, Marie Krousel-Wood,

<h4>Purpose of review</h4>Enabled by widespread technological advancements, electronic health (eHealth) strategies have expanded rapidly over the last decade, presenting opportunities to support self-management including medication adherence for cardiometabolic disease control. eHealth can minimize access barriers to medications, enable timely assessment and shared decision-making, and provide medication reminders and health data feedback. This review summarizes current evidence for effectiveness of eHealth strategies for improving medication adherence in patients with hypertension, type 2 diabetes, and/or hyperlipidemia, and identifies priorities for future research.<h4>Recent findings</h4>Current research supports the effectiveness of eHealth strategies to improve medication adherence and clinical outcomes for cardiometabolic disease. Although patient acceptability of eHealth strategies is generally high, engagement may decline over time. In addition, differences in effectiveness across intervention characteristics and sociodemographic groups are understudied, limiting generalizability and tailoring of interventions to local health system resources, culture, and patient needs or preferences.<h4>Summary</h4>eHealth is a promising tool for addressing low medication adherence. Further work incorporating rigorous evaluation, assessment of patient engagement over time and effectiveness of intervention characteristics and components, and a health equity lens addressing eHealth use in vulnerable groups will increase understanding of the full potential of eHealth for improving medication adherence in diverse patients with cardiometabolic disease.

Curr Opin Cardiol (Current opinion in cardiology)
[2022, 37(4):307-316]

Cited: 0 times

AltMetric Statistics




Advertisement


Disclaimer

0.4157 s